[PDF] Top 20 Alternative therapies to radiotherapy and chemotherapy in breast cancer
Has 10000 "Alternative therapies to radiotherapy and chemotherapy in breast cancer" found on our website. Below are the top 20 most common "Alternative therapies to radiotherapy and chemotherapy in breast cancer".
Alternative therapies to radiotherapy and chemotherapy in breast cancer
... consists in blocking the stimulation that estrogens exert on the tumor, to prevent its ...the therapies with the greatest clinical use, taking part in the main therapeutic scheme for ... See full document
50
Título26,26,26,27,27,27 Hexadeuterated 1,25 Dihydroxyvitamin D3 (1,25D d6) As Adjuvant of Chemotherapy in Breast Cancer Cell Lines
... subjected to SDS–PAGE electrophoresis. Proteins were transferred to a nitrocellulose membrane, blocked, and immunolabeled overnight at 4 °C with a primary antibody, and then incubated with the ... See full document
12
Circulating Tumor Cells Following First Chemotherapy Cycle: An Early and Strong Predictor of Outcome in Patients With Metastatic Breast Cancer
... objective and was reflected in the design of the ...enough to allow for conclusions about long-term outcome: 59% of deaths and a median follow-up of 35 months for the patients still ... See full document
7
Bone impact in breast cancer treatment
... Breast cancer is one of the most frequent tumors in ...both. In the last decade, breast cancer mortality has decreased by 6-8 ...due to early screening and ... See full document
15
Exosomal miRNA profile as complementary tool in the diagnostic and prediction of treatment response in localized breast cancer under neoadjuvant chemotherapy
... served in our study was the correlation between EmiR expression and disease ...differences in EmiR-105 levels between localized BC and healthy ...disease and subsequent finest treatment ... See full document
9
Breast cancer epidemiology: mammographic screening and molecular subtypes
... roles in the molecular pathways that lead to the survival and proliferation of breast ...pathways in order to control cell cycle and tumour ...ER and/or ... See full document
148
Manejo odontológico de las complicaciones orales secundarias al tratamiento oncológico con quimioterapia y radioterapia. (Dental Management of oral complications secondary to cancer treatment with chemotherapy and radiotherapy)
... aim to documenting the importance of dental management of oral complications secondary to cancer treatment with chemotherapy and radiotherapy; these are used either as mono ... See full document
8
Bioenergetics mechanism and autophagy in breast cancer stem cells
... obtainable in humans, but they might not be ideal due to the pharmacology of the ...temsirolimus) and/or radiation, has been shown to have low response rates in preliminary clinical ... See full document
305
Metastasis dormancy in estrogen receptor-positive breast cancer.
... stone to have a 5-cm asymp- tomatic osteolytic lesion in the pelvis proven on biopsy to be an ER þ breast cancer metastasis developing 22 years after her primary tumor diagnosis ... See full document
10
Association between baseline VEGF/sVEGFR 2 and VEGF/TSP 1 ratios and response to metronomic chemotherapy using cyclophosphamide and celecoxib in patients with advanced breast cancer
... Committee and by ...required. In brief, patients (age, 18–80 years) with histologically confirmed advanced breast cancer progressing after three, and no more than four, ... See full document
7
How much survival benefit is necessary for breast cancer patients to opt for adjuvant chemotherapy? Results from a Chilean survey
... us to predict BC relapse are based on the assessment of pathologic tumour ...status, and epidermal growth factor recep- tor type 2 (Her-2) are classical determinants to define ...therapeutic ... See full document
9
Insulin like growth factor 2 promotes ovarian cancer growth and resistance to traditional chemotherapy
... how to target IGF2-mediated drug resistance, we examined receptor expression and activation in the drug resistant and sensitive cell ...IGF1R and the insulin receptor isoform A, IR-A ... See full document
149
Metastatic breast cancer patients treated with low dose metronomic chemotherapy with cyclophosphamide and celecoxib: clinical outcomes and biomarkers of response
... VEGF and VEGF/sVEGFR-2 ratio with TTP was significant, and patients with values below both 50th percentiles, showed higher TTP, suggesting them as potential candidates for predictor biomarkers of response ... See full document
25
Combined low initial DNA damage and high radiation-induced apoptosis confers clinical resistance to long-term toxicity in breast cancer patients treated with high-dose radiotherapy
... related to severe late toxicity in breast cancer patients ...toxicity. In the pre- sent set of patients, no association was observed between DNA DSB or RIA (at any radiation dose), a or ... See full document
8
Radiotherapy for Metastatic Breast Cancer in Mexico: Results from the 2015 National Survey
... keystone to improve survival and quality of life in breast cancer ...patients. In Mexico, how- ever, scarce information is available on the obstacles faced by radio-oncologists ... See full document
9
Early and late skin reactions to radiotherapy for breast cancer and their correlation with radiation-induced DNA damage in lymphocytes
... (SNPs) and the risk of radiation-induced nor- mal tissue reactions in a small group of breast cancer patients ...[33]. In fact, the completion of the human genome project and the ... See full document
9
Safety and therapeutic effect of metronomic chemotherapy with cyclophosphamide and celecoxib in advanced breast cancer patients
... order to find possible markers of response to therapy, we evaluated serum levels of VEGF and TSP-1 and percentages of circulating CECs and ...limitations in the number of ... See full document
27
Predictive models for pulmonary function changes after radiotherapy for breast cancer and lymphoma
... aiming to identify good predictors for a well- defined set of endpoints (changes in lung function, chest radiographies, clinical symptoms, and others) in a group of healthy lung patients ... See full document
8
Predicting response and survival in chemotherapy-treated triple-negative breast cancer.
... (Prat and Perou, 2011). In addition, the proportion of BLBCs within TNBC varies substantially from cohort to cohort (Prat and Perou, 2011; Table ...TNBC and additional efforts are ... See full document
10
Predictive value of apoptosis, proliferation, HER 2, and topoisomerase IIalpha for anthracycline chemotherapy in locally advanced breast cancer
... tosis) and cell proliferation determines tumor growth, and any, alteration between the two factors is a key ele- ment for the uncontrolled expansion of malignant tu- mors ...apoptosis, and failure of ... See full document
8
Related subjects